http://www.acc.org/Feed?clinicalTopicID=f24e6d2b-ba21-4c56-871d-d44e86eba30b Clinical Topic Feed: Cardiac Surgery and VHD en /Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/JACC-Journals-Science-From-EuroPCR-2026 Findings from four late-breaking clinical trials presented at EuroPCR 2026 in Paris, France, were simultaneously published in JACC: Cardiovascular Interventions. Together they lend new insights into residual tricuspid regurgitation (TR) after tricuspid valve transcatheter edge-to-edge repair (T-TEER), the safety of transfemoral (TF) transcatheter mitral valve replacement (TMVR), the novel BATMAN-TMVR technique, and the effect of implant depth on TAVR outcomes. 1779371700000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/22/49/Joint-Statement The Society for Cardiovascular Angiography & Interventions (SCAI), American College of Cardiology (ACC), and Society of Thoracic Surgeons (STS), on May 1, released the following joint statement in response to recent media coverage about Transcatheter Aortic Valve Replacement (TAVR) and Surgical Aortic Valve Replacement (SAVR):... 1777679520000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/21/15/23/ACC26-Structural-Intervention-Trials-Offer-Viable-Options Late-breaking clinical trials presented at ACC.26 focusing on structural interventions included the PROTECT H2H trial comparing two embolic protection devices (EPDs) in patients undergoing transcatheter aortic valve implantation (TAVI), the PRO-TAVI trial comparing a strategy of routine PCI with a deferred approach... 1776939000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/22/13/48/eagles-eye-view-22apr2026 In this week’s Eagle's Eye View, Dr. Eagle examines early surgery for asymptomatic patients with severe aortic stenosis. 1776865800000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/15/17/20/Does-Early-Surgery Early surgical aortic valve replacement (SAVR) led to a lower incidence of operative mortality or cardiovascular-related death at 10 years in patients with very severe aortic stenosis (AS), according to an extended follow-up of the RECOVERY trial published March 25 in NEJM. 1776358260000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/13/18/35/Transcatheter-Aortic-Valve-Implantation Transcatheter aortic valve implantation (TAVI) has become a cornerstone therapy for patients with severe aortic stenosis across a wide spectrum of clinical presentations and surgical risk. Initially reserved for patients at prohibitive or high surgical risk, TAVI is now widely adopted in populations at intermediate and low risk... 1776119820000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Mission-in-Action-Medtronic-Clinician-Update New long-term data from the Evolut Low Risk trial published in JACC underscore how emerging science and evidence continue to shape patient-centered care in structural heart disease – an approach central to the ACC's Vision of using science, knowledge and innovation to optimize patient care and outcomes. 1775045220000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-protavi-acc-2026 Older patients with coronary artery disease (CAD) for whom PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study presented in a Late-Breaking Clinical Trial session... 1774818600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-protecth2h-acc-2026 In the first head-to-head comparison of two embolic protection devices used during TAVR, the investigational Emboliner protection catheter performed comparably to the U.S. Food and Drug Administration (FDA)-approved Sentinel cerebral protection system relative to the composite primary endpoint and secondary endpoint of stroke, according to results from the PROTECT H2H trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/18/11/31/Trilogy-TAVI-For-Native-Aortic-Regurgitation The ALIGN-AR (TAVR With JenaValve for Symptomatic Aortic Regurgitation in High Surgical Risk Patients) trial findings demonstrated that, among patients with symptomatic moderate-to-severe or severe native aortic regurgitation (AR) at high surgical risk, transcatheter aortic valve implantation (TAVI) using the Trilogy valve... 1773930000000 Articles and Stories